Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

ALBT

Avalon GloboCare Corp

Jun 14 • 04:00PM ET

0.4504

Dollar change -0.0198
Percentage change -4.21	%

Real Estate • Real Estate Services • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	55.99%	Shs Outstand	11.00M	Perf Week	-4.13%
Market Cap	4.58M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.47M	Perf Month	70.74%
Income	-14.95M	PEG	-	EPS next Q	-	Inst Own	0.98%	Short Float	2.06%	Perf Quarter	32.47%
Sales	1.27M	P/S	3.60	EPS this Y	-	Inst Trans	-35.50%	Short Ratio	0.03	Perf Half Y	-7.89%
Book/sh	-1.26	P/B	-	EPS next Y	-	ROA	-58.28%	Short Interest	0.09M	Perf Year	-77.59%
Cash/sh	0.03	P/C	14.76	EPS next 5Y	-	ROE	-115.17%	52W Range	0.24 - 2.14	Perf YTD	-6.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.00%	ROI	-119.32%	52W High	-78.95%	Beta	0.30
Dividend TTM	-	Quick Ratio	0.08	Sales past 5Y	-4.02%	Gross Margin	16.21%	52W Low	87.67%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	0.08	EPS Y/Y TTM	-7.67%	Oper. Margin	-429.19%	RSI (14)	50.49	Volatility	9.24% 36.92%
Employees	5	Debt/Eq	1.39	Sales Y/Y TTM	6.11%	Profit Margin	-1173.45%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	1.07	EPS Q/Q	55.40%	Payout	-	Rel Volume	0.12	Prev Close	0.47
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	6.22%	Earnings	-	Avg Volume	2.77M	Price	0.45
SMA20	1.21%	SMA50	27.49%	SMA200	-12.80%	Trades		Volume	318,810	Change	-4.21%

Jun-04-24 11:00AM	Paramount Layoffs 2024: What to Know About the Latest PARA Job Cuts (InvestorPlace) -30.60%
08:55AM	Why Is Avalon Globocare (ALBT) Stock Down 27% Today? (InvestorPlace)
07:28AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-03-24 02:53PM	ALBT Stock Earnings: Avalon Globocare Reported Results for Q1 2024 (InvestorPlace) +316.95%
May-24-24 05:00PM	Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report (GlobeNewswire) +9.03%
08:30AM	Loading…
May-21-24 08:30AM	La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors (GlobeNewswire) -5.78%
Apr-22-24 09:00AM	Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference (GlobeNewswire) -6.38%
Apr-16-24 09:52AM	ALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023 (InvestorPlace)
Mar-28-24 09:00AM	Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union (GlobeNewswire) +5.79%
Dec-18-23 09:00AM	Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US (GlobeNewswire) +20.23%
Oct-18-23 09:00AM	Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis (GlobeNewswire) +22.65%
Oct-04-23 09:00AM	Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application (GlobeNewswire)
Sep-13-23 09:15AM	Avalons Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device (GlobeNewswire)
Sep-05-23 08:00AM	Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT) (GlobeNewswire) +27.00%
Aug-30-23 10:45AM	EXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosis (Benzinga) +9.57%
09:00AM	Loading…
09:00AM	Avalons Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis (GlobeNewswire)
Aug-21-23 09:00AM	Avalons Laboratory Services MSO Announces Expansion into Arizona (GlobeNewswire)
Jul-24-23 09:00AM	Avalons Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth (GlobeNewswire)
Jul-19-23 09:00AM	Avalon GloboCares Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States (GlobeNewswire) +11.36%
Jul-10-23 09:00AM	Avalon GloboCare Provides Update on New Commercial Strategy (GlobeNewswire)
Apr-27-23 09:00AM	Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022 (GlobeNewswire) +6.70%
Apr-17-23 09:00AM	Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conference (GlobeNewswire)
Apr-11-23 09:00AM	Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union (GlobeNewswire) +17.98%
Mar-03-23 09:00AM	Avalon GloboCare to Participate in the 35th Annual Roth Conference (GlobeNewswire)
Feb-13-23 09:00AM	Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company (GlobeNewswire) +16.99%
Jan-17-23 09:00AM	Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules (GlobeNewswire)
Jan-11-23 09:00AM	Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors (GlobeNewswire) -11.06%
Jan-03-23 09:00AM	Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology (GlobeNewswire) +7.69%
Dec-14-22 09:00AM	Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Companys Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services (GlobeNewswire) +10.58%
Dec-12-22 09:00AM	Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC (GlobeNewswire) +18.78%

Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALBT

Avalon GloboCare Corp

Upgrade your FINVIZ experience